ElyssaM.RubinMD
Pediatric Hematology & Oncology • Orange, CAAssistant Professor, Pediatrics, University of California, Irvine College of Medicine
Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
455 S Main St
Orange, CA 92868Phone+1 714-516-4348Fax+1 714-532-8699
Summary
- Dr. Elyssa Rubin is a pediatric hematologist/oncologist in Orange, CA and is affiliated with multiple hospitals in the area, including UCI Medical Center, St. Joseph Hospital Orange, and Children’s Health Orange County (CHOC). She received her medical degree from Tel Aviv University Sackler and has been in practice 15 years. She is director of the bone and soft tissue tumor program at CHOC and specializes in malignant bone tumors, Neuroblastoma, and other pediatric sarcomas and solid tumors. She is also involved with clinical trial harmonization work with PCDC and has leadership positions in the COG bone tumor committee, international bone tumor consortium HIBiSCus, and regional consortium UCCAAYAC.
Education & Training
University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Kaiser Permanente Southern California (Los Angeles)Residency, Pediatrics, 2002 - 2005
Tel Aviv University SacklerClass of 2002
Duke UniversityBS, Biology and English, 1992 - 1996
Certifications & Licensure
CA State Medical License 2004 - 2026- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence Start of enrollment: 2014 Jul 01
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsFrzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signalingYi Guo, Jun Xie, Elyssa Rubin, Yaxiong Tang, Fritz Lin
Cancer Research. 2008-05-01 - 60 citationsDominant Negative LRP5 Decreases Tumorigenicity and Metastasis of Osteosarcoma in an Animal ModelYi Guo, Elyssa Rubin, Jun Xie, Xiaolin Zi, Bang H. Hoang
Clinical Orthopaedics and Related Research. 2008-06-20 - 5 citationsBad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas.Georgina E Wood, Laurie A Graves, Elyssa M Rubin, Damon R Reed, Richard F Riedel
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-05-01
Journal Articles
- Congenital Neuroglial choristoma of the footGlavis-Bloom J, Nahl D, Rubin EM, Nael A, Dao T., Radiology Case Reports, 6/14/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
